IMDX
Insight Molecular Diagnostics
IMDX
IMDX
56 hedge funds and large institutions have $39.9M invested in Insight Molecular Diagnostics in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more capital invested
Capital invested by funds: $39.8M → $39.9M (+$108K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $7K
Holders
56
Holding in Top 10
1
Calls
–
Puts
$7K
Top Buyers
| 1 | +$6.3M | |
| 2 | +$369K | |
| 3 | +$353K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$210K |
| 5 |
DAM
Doheny Asset Management
Los Angeles,
California
|
+$175K |
Top Sellers
| 1 | -$550K | |
| 2 | -$474K | |
| 3 | -$472K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$229K |
| 5 |
Jane Street
New York
|
-$178K |